Torsten Falk - Related publications

Affiliations: 
Neurology University of Arizona, Tucson, AZ 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Yao L, Wu J, Koc S, Lu G. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements. Frontiers in Cell and Developmental Biology. 9: 655819. PMID 34336822 DOI: 10.3389/fcell.2021.655819   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, Blandini F, Cerri S. Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease. International Journal of Molecular Sciences. 22. PMID 34445626 DOI: 10.3390/ijms22168920   
2021 Zhu G, Wang W, Chen C, Tang L, Liang Y, Zhang Z, Lu Y, Zhao Y. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson's disease mice after oral administration of Wen-Shen-Yang-Gan decoction. Aging. 13. PMID 34339394 DOI: 10.18632/aging.203361   
2021 Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451872 DOI: 10.3390/ph14080775   
2021 Ren C, Wang F, He KJ, Zhang YT, Li LX, Zhang JB, Chen J, Mao CJ, Liu CF. Early-life stress induces prodromal features of Parkinsonian with aging in rats. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34448826 DOI: 10.1093/gerona/glab253   
2021 Ma YF, Lin YA, Huang CL, Hsu CC, Wang S, Yeh SR, Tsai YC. Lactiplantibacillus plantarum PS128 Alleviates Exaggerated Cortical Beta Oscillations and Motor Deficits in the 6-Hydroxydopamine Rat Model of Parkinson's Disease. Probiotics and Antimicrobial Proteins. PMID 34449056 DOI: 10.1007/s12602-021-09828-x   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Taghizadeh E, Gheibihayat SM, Taheri F, Afshani SM, Farahani N, Saberi A. LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 34254198 DOI: 10.1007/s10072-021-05408-7   
2021 Bastioli G, Regoni M, Cazzaniga F, De Luca CMG, Bistaffa E, Zanetti L, Moda F, Valtorta F, Sassone J. Animal Models of Autosomal Recessive Parkinsonism. Biomedicines. 9. PMID 34356877 DOI: 10.3390/biomedicines9070812   
2021 Pottenger AE, Bartlett MJ, Sherman SJ, Falk T, Morrison HW. Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment. Neuroscience Letters. 136251. PMID 34536508 DOI: 10.1016/j.neulet.2021.136251   
2021 Pagonabarraga J, Tinazzi M, Caccia C, Jost WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 90: 178-183. PMID 34275546 DOI: 10.1016/j.jocn.2021.05.056   
2021 Kim GJ, Mo H, Liu H, Wu Z, Chen S, Zheng J, Zhao X, Nucum D, Shortland J, Peng L, Elepano M, Tang B, Olson S, Paras N, Li H, et al. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. Elife. 10. PMID 34550070 DOI: 10.7554/eLife.69795   
2021 Houser MC, Caudle WM, Chang J, Kannarkat GT, Yang Y, Kelly SD, Oliver D, Joers V, Shannon KM, Keshavarzian A, Tansey MG. Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathologica Communications. 9: 139. PMID 34412704 DOI: 10.1186/s40478-021-01240-4   
2021 Deng I, Corrigan F, Garg S, Zhou XF, Bobrovskaya L. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice. International Journal of Molecular Sciences. 22. PMID 34299000 DOI: 10.3390/ijms22147380   
2021 Lin TK, Lin KJ, Lin HY, Lin KL, Lan MY, Wang PW, Wang TJ, Wang FS, Tsai PC, Liou CW, Chuang JH. Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress. Frontiers in Molecular Neuroscience. 14: 697440. PMID 34305527 DOI: 10.3389/fnmol.2021.697440   
2021 Tozzi A, Sciaccaluga M, Loffredo V, Megaro A, Ledonne A, Cardinale A, Federici M, Bellingacci L, Paciotti S, Ferrari E, La Rocca A, Martini A, Mercuri NB, Gardoni F, Picconi B, et al. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Brain : a Journal of Neurology. PMID 34297092 DOI: 10.1093/brain/awab242   
2021 Heurtaux T, Kirchmeyer M, Koncina E, Felten P, Richart L, Uriarte Huarte O, Schohn H, Mittelbronn M. Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway. Cellular and Molecular Neurobiology. PMID 34415465 DOI: 10.1007/s10571-021-01131-1   
2021 Jiang W, Zou W, Hu M, Tian Q, Xiao F, Li M, Zhang P, Chen YJ, Jiang JM. Hydrogen sulfide attenuates neuronal apoptosis of substantia nigra by reestablishing autophagic flux via promoting leptin signaling in a 6-hydroxydopamine rat model of Parkinson's disease. Clinical and Experimental Pharmacology & Physiology. PMID 34494284 DOI: 10.1111/1440-1681.13587   
2021 Van Laar AD, Van Laar VS, San Sebastian W, Merola A, Bradley Elder J, Lonser RR, Bankiewicz KS. An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function. Journal of Parkinson's Disease. PMID 34366374 DOI: 10.3233/JPD-212724   
2021 Fieblinger T. Striatal Control of Movement: A Role for New Neuronal (Sub-) Populations? Frontiers in Human Neuroscience. 15: 697284. PMID 34354577 DOI: 10.3389/fnhum.2021.697284   
2021 Feng Y, Zhou S, Sun J. Exercise increases striatal Glu reuptake and improves motor dysfunction in 6-OHDA-induced Parkinson's disease rats. Experimental Brain Research. PMID 34463828 DOI: 10.1007/s00221-021-06186-6   
2021 Ma X, Wang Q, Yuan W, Wang Y, Zhou F, Kang K, Tong X, Liu Z. Electroacupuncture Alleviates Neuroinflammation and Motor Dysfunction by Regulating Intestinal Barrier Function in a Mouse Model of Parkinson Disease. Journal of Neuropathology and Experimental Neurology. PMID 34343334 DOI: 10.1093/jnen/nlab046   
2021 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Molecular Medicine Reports. 24. PMID 34414447 DOI: 10.3892/mmr.2021.12374   
2021 Mottaghi S, Kohl S, Biemann D, Liebana S, Montaño Crespo RE, Buchholz O, Wilson M, Klaus C, Uchenik M, Münkel C, Schmidt R, Hofmann UG. Bilateral Intracranial Beta Activity During Forced and Spontaneous Movements in a 6-OHDA Hemi-PD Rat Model. Frontiers in Neuroscience. 15: 700672. PMID 34456673 DOI: 10.3389/fnins.2021.700672   
2021 Jaiswal V, Alquraish D, Sarfraz Z, Sarfraz A, Nagpal S, Singh Shrestha P, Mukherjee D, Guntipalli P, Sánchez Velazco DF, Bhatnagar A, Savani S, Halilaj E, Ruxmohan S, Cueva W. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review. Journal of Primary Care & Community Health. 12: 21501327211039709. PMID 34404266 DOI: 10.1177/21501327211039709   
2021 Prasad EM, Hung SY. Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451813 DOI: 10.3390/ph14080717   
2021 Bian LH, Yao ZW, Zhao CB, Li QY, Shi JL, Guo JY. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor. Evidence-Based Complementary and Alternative Medicine : Ecam. 2021: 6686965. PMID 34426745 DOI: 10.1155/2021/6686965   
2021 Lin Y, Xu D, Gao F, Zheng X. Ulinastatin inhibits NLRP3-induced apoptosis in a PD cell model. Annals of Translational Medicine. 9: 924. PMID 34350239 DOI: 10.21037/atm-21-1882   
2021 Iyer V, Venkiteswaran K, Savaliya S, Lieu CA, Handly E, Gilmour TP, Kunselman AR, Subramanian T. The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias. Neurobiology of Disease. 105491. PMID 34461264 DOI: 10.1016/j.nbd.2021.105491   
2021 Zhao Z, Niu Y, Chen P, Zhu Y, Shi L, Zhao X, Wang C, Zhang Y, Gao Z, Jiang W, Ren W, Gu R, Yu Y. Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats. Neural Plasticity. 2021: 9938566. PMID 34367273 DOI: 10.1155/2021/9938566   
2021 Wang L, Sheng W, Tan Z, Ren Q, Wang R, Stoika R, Liu X, Liu K, Shang X, Jin M. Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments. Comparative Biochemistry and Physiology. Toxicology & Pharmacology : Cbp. 109151. PMID 34343700 DOI: 10.1016/j.cbpc.2021.109151   
2021 Elshennawy M, Ouachikh O, Shereen Adel Saad, Ramadan Y, Durif F, Hafidi A. Nigrostriatal dopamine depletion promoted an increase in inhibitory markers (parvalbumin, GAD67, VGAT) and cold allodynia. Neuroscience Letters. 762: 136135. PMID 34311052 DOI: 10.1016/j.neulet.2021.136135   
2021 Singh A, Yadawa AK, Chaturvedi S, Wahajuddin M, Mishra A, Singh S. Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 155: 112433. PMID 34302886 DOI: 10.1016/j.fct.2021.112433   
2021 Liu D, Gu X, Han F, Cai M, Liu W, Han L, Ma Q. The protective effects of Ramelteon against 6-OHDA-induced cellular senescence in human SH-SY5Y neuronal cells. Brain and Behavior. PMID 34296537 DOI: 10.1002/brb3.2278   
2021 Srivastava R, Choudhury PK, Dev SK, Rathore V. Neuroprotective effect of α-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-Parkinson's effect. Journal of Biochemical and Molecular Toxicology. e22902. PMID 34464010 DOI: 10.1002/jbt.22902   
2021 Zheng C, Zhang F. New Insights into Pathogenesis of L-DOPA-Induced Dyskinesia. Neurotoxicology. PMID 34331976 DOI: 10.1016/j.neuro.2021.07.006   
2021 Wang H, Liu Y, Zhao J, Guo X, Hu M, Chen Y. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review). Clinical Neurology and Neurosurgery. 208: 106844. PMID 34388595 DOI: 10.1016/j.clineuro.2021.106844   
2021 Barker RA, Björklund A, Frucht SJ, Svendsen CN. Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease? Journal of Parkinson's Disease. 11: 909-917. PMID 34334425 DOI: 10.3233/JPD-219008   
2021 Du ZR, Gu Y, Xie XM, Zhang M, Jiang GY, Chen WF. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats. The Journal of Steroid Biochemistry and Molecular Biology. 105989. PMID 34478828 DOI: 10.1016/j.jsbmb.2021.105989   
2021 Scheffer DDL, Freitas FC, Aguiar AS, Ward C, Guglielmo LGA, Prediger RD, Cronin SJF, Walz R, Andrews NA, Latini A. Impaired dopamine metabolism is linked to fatigability in mice and fatigue in Parkinson's disease patients. Brain Communications. 3: fcab116. PMID 34423297 DOI: 10.1093/braincomms/fcab116   
2021 Gong J, Zhang W, Ding L, Zhang M, Zheng S, Ma R, Tang J, Yi W, Xu H, Zhang Y. 4,4'-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson's disease therapy. Free Radical Biology & Medicine. PMID 34332078 DOI: 10.1016/j.freeradbiomed.2021.07.038   
2021 Mustafa R, Rawas C, Mannal N, Kreiner G, Spittau B, Kamińska K, Yilmaz R, Pötschke C, Kirsch J, Liss B, Tucker KL, Parlato R. Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress. Antioxidants (Basel, Switzerland). 10. PMID 34439532 DOI: 10.3390/antiox10081284   
2021 Tamilanban T, Manasa K, Chitra V. In silico docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's disease and its In vivo Evaluation by Zebrafish Model. Cns & Neurological Disorders Drug Targets. PMID 34477539 DOI: 10.2174/1871527320666210903091447   
2021 Silva-Martins S, Beserra-Filho JIA, Maria-Macêdo A, Custódio-Silva AC, Soares-Silva B, Silva SP, Lambertucci RH, Silva RH, Santos JR, Gandhi SR, Quintans-Júnior LJ, Ribeiro AM. Myrtenol complexed with β-cyclodextrin ameliorates behavioral deficits and reduces oxidative stress in the reserpine-induced animal model of parkinsonism. Clinical and Experimental Pharmacology & Physiology. PMID 34351001 DOI: 10.1111/1440-1681.13563   
2021 Mitkova Z, Kamusheva M, Kalpachka D, Ignatova D, Tachkov K, Petrova G. Review of medicine utilization for Parkinson's disease management: the Bulgarian perspective. Journal of Public Health Research. PMID 34351100 DOI: 10.4081/jphr.2021.2396   
2021 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metabolic Brain Disease. PMID 34370175 DOI: 10.1007/s11011-021-00808-2   
2021 Nakamura Y, Arawaka S, Sato H, Sasaki A, Shigekiyo T, Takahata K, Tsunekawa H, Kato T. Monoamine oxidase-B inhibition facilitates α-synuclein secretion and delays its aggregation in rAAV-based rat models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34290084 DOI: 10.1523/JNEUROSCI.0476-21.2021